GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) » Definitions » Net Margin %

Cabio Biotech (Wuhan) Co (SHSE:688089) Net Margin % : 20.78% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cabio Biotech (Wuhan) Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Cabio Biotech (Wuhan) Co's Net Income for the three months ended in Mar. 2024 was ¥24.3 Mil. Cabio Biotech (Wuhan) Co's Revenue for the three months ended in Mar. 2024 was ¥117.0 Mil. Therefore, Cabio Biotech (Wuhan) Co's net margin for the quarter that ended in Mar. 2024 was 20.78%.

The historical rank and industry rank for Cabio Biotech (Wuhan) Co's Net Margin % or its related term are showing as below:

SHSE:688089' s Net Margin % Range Over the Past 10 Years
Min: 10.79   Med: 26.76   Max: 40.37
Current: 21.43


SHSE:688089's Net Margin % is ranked better than
90.14% of 1024 companies
in the Biotechnology industry
Industry Median: -148.36 vs SHSE:688089: 21.43

Cabio Biotech (Wuhan) Co Net Margin % Historical Data

The historical data trend for Cabio Biotech (Wuhan) Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cabio Biotech (Wuhan) Co Net Margin % Chart

Cabio Biotech (Wuhan) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.93 40.37 36.62 14.85 20.59

Cabio Biotech (Wuhan) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.30 18.50 20.28 26.02 20.78

Competitive Comparison of Cabio Biotech (Wuhan) Co's Net Margin %

For the Biotechnology subindustry, Cabio Biotech (Wuhan) Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cabio Biotech (Wuhan) Co's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cabio Biotech (Wuhan) Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Cabio Biotech (Wuhan) Co's Net Margin % falls into.



Cabio Biotech (Wuhan) Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Cabio Biotech (Wuhan) Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=91.374/443.803
=20.59 %

Cabio Biotech (Wuhan) Co's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=24.313/117.02
=20.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cabio Biotech (Wuhan) Co  (SHSE:688089) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Cabio Biotech (Wuhan) Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Cabio Biotech (Wuhan) Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cabio Biotech (Wuhan) Co (SHSE:688089) Business Description

Traded in Other Exchanges
N/A
Address
No. 999, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, CHN, 430073
Cabio Biotech (Wuhan) Co Ltd is a biotechnology company, engaged in Research & Development, production and sales of polyunsaturated fatty acids ARA, algae oil DHA and SA, natural B-carotene and other series products. The products are used in infant formula, dietary nutrition supplements and health Food, special medical formula food and other fields. The company's product sales area covers China, the United States, Europe, Australia, New Zealand, South Korea, and Southeast Asia.
Executives
Shang Yun Core technical personnel
Wang Hua Biao Directors, senior managers
Geng An Feng senior management
Du Bin Director
Yi Hua Rong senior management
Ma Tao senior management
Li Xiang Yu senior management
Wu Yu Jun Supervisors
Xiao Min senior management
Wang Zhi Ming senior management
Lu Shu Huan Core technical personnel
Yi De Wei Director

Cabio Biotech (Wuhan) Co (SHSE:688089) Headlines

No Headlines